Gastrointestinal Tumors

• CLINICAL_TRIALS research · 2025-01-28
  Clinical Trial Update: Combined Screening for Gastrointestinal Tumors

  This clinical trial update describes a combined screening approach for gastrointestinal tumors, sponsored by Zhejiang Cancer Hospital, which…

• CLINICAL_TRIALS trial_result · 2024-03-27
  Clinical Trial Update: Research on the Correlation Between Organoid Drug Sensitivity Testing and Precise Treatment of Gastrointestinal Tumors [Phase 3]

  A Phase 3 trial evaluating the correlation between organoid drug sensitivity testing and precise treatment for gastrointestinal tumors.

• CLINICAL_TRIALS trial_result · 2023-11-28
  Clinical Trial Update: Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001) [Phase 2]

  Phase 2 trial update evaluating anlotinib plus chemotherapy as first-line therapy for gastrointestinal tumors with unresectable liver metast…

• CLINICAL_TRIALS trial_result · 2023-10-16
  Clinical Trial Update: Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors [Phase 3]

  Phase 3 clinical trial evaluating the effects of immunonutrition on reducing adverse reactions from postoperative adjuvant chemotherapy in p…

• CLINICAL_TRIALS trial_result · 2022-11-29
  Clinical Trial Update: A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors [Phase 1, Phase 2]

  Phase 1/2 study exploring donafenib in combination with KN046 for advanced gastrointestinal tumors; current status is unknown.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-06-17
  Clinical Trial Update: A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors [Phase 2]

  Phase 2 clinical trial update for anlotinib and AK105 injection in patients with gastrointestinal, urinary system, and neuroendocrine tumors…

• CLINICAL_TRIALS research · 2018-02-13
  Clinical Trial Update: The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies [Phase 4]

  Phase 4 trial evaluating whether preoperative oral glutamine affects immunocompetence and outcomes in malnourished patients undergoing major…

• CLINICAL_TRIALS trial_result · 2016-09-16
  Clinical Trial Update: Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors [Phase 1]

  A Phase 1 pilot study evaluating the combination of sorafenib and bi-weekly capecitabine in patients with metastatic breast cancer and gastr…